Domov › Rak prostate › Illinois

Klinične študije za Rak prostate v Illinois

64 študij za Rak prostate išče udeležence na lokacijah v Illinois.

Mesta v Illinois

Uradno besedilo študije (angleško)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Illinois CancerCare-Carthage, Carthage
in še 31

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Northwestern University, Chicago
Cancer Care Specialists of Illinois - Decatur, Decatur
Decatur Memorial Hospital, Decatur
in še 8

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 2. okt. 2026 · NCT07200830

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
in še 54

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Carle at The Riverfront, Danville
in še 11

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06632977

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06172478

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Rush MD Anderson Cancer Center, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Carle at The Riverfront, Danville
in še 12

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 30. sep. 2026 · NCT03866382

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Northwestern Medicine Chicago Proton Center, Warrenville

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 29. sep. 2026 · NCT01492972

Precision-Based Genomics in Prostate Cancer

NorthShore University HealthSystem, Evanston

Vključevanje udeležencevOpazovalna študija

Starost 18–120 · Moški · Posodobljeno 28. sep. 2026 · NCT04706663

DESTINY-PANTUMOUR04

Research Site, Decatur

Vključevanje udeležencevOpazovalna študija

Starost 18–130 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07124000

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Illinois Cancer Care ( Site 0104), Peoria

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Associated Urological Specialists - Chicago Ridge, Chicago Ridge
Cancer Care Specialists of Illinois, Decatur
Cancer Care Specialists of Illinois, O'Fallon

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 24. sep. 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

University of Chicago, Chicago

Vključevanje udeležencevFaza 2/3

Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

University of Illinois Chicago, Chicago
Cancer Care Specialists of Illinois, Decatur
Midwestern Regional Medical Center dba City of Hope Chicago, Zion

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 22. sep. 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Northwestern University, Chicago
University of Illinois Cancer Center at Chicago, Chicago

Vključevanje udeležencevFaza 3

Starost 18–100 · Moški · Posodobljeno 22. sep. 2026 · NCT06855277

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, Chicago
Research Site, Chicago Ridge

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 18. sep. 2026 · NCT06952803

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Rush University Medical Center-Hematology and Oncology ( Site 0028), Chicago
University of Illinois at Chicago-University of Illinois Cancer Center ( Site 0063), Chicago

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 17. sep. 2026 · NCT06925737

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

NorthShore University Health System, Glenbrook Hospital, Glenview

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 11. sep. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Alton Memorial Hospital, Alton
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
in še 39

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 10. sep. 2026 · NCT05946213

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

University of Illinois Hospital & Health Sciences System, Chicago

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 8. sep. 2026 · NCT05800665

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Associated Urological Specialists, Chicago Ridge
NorthShore University HealthSystem, Evanston

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 3. sep. 2026 · NCT07005154

MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

University of Chicago Medicine Comprehensive Cancer Center, Chicago

Vključevanje udeležencev

Starost 18 in več · Moški · Posodobljeno 1. sep. 2026 · NCT05710380

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

University of Chicago Comprehensive Cancer Center, Chicago
Endeavor Health, Evanston

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 31. avg. 2026 · NCT05726292

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, O'Fallon

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 26. avg. 2026 · NCT07611110

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Jesse Brown VA Medical Center, Chicago, IL, Chicago

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 25. avg. 2026 · NCT05593497

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

University of Chicago, Chicago

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Moški · Posodobljeno 20. avg. 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Alton Memorial Hospital, Alton
OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
in še 42

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 19. avg. 2026 · NCT04423211

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

University of Chicago Medical Center, Chicago

Vključevanje udeležencevFaza 1

Starost 18–100 · Moški · Posodobljeno 13. avg. 2026 · NCT05519449

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Chicago

Vključevanje udeležencevFaza 1/2

Starost 18–130 · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT05417594

PSMA PET Combined With MRI for the Detection of PCa

UroPartners,LLC, Chicago

Vključevanje udeležencevFaza 3Vabljeni zdravi prostovoljci

Starost 18 in več · Moški · Posodobljeno 23. jul. 2026 · NCT07052214

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Rush MD Anderson, Chicago

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 22. jul. 2026 · NCT06274047

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

University of Illinois, Chicago
Elmhurst Memorial Hospital, Elmhurst
Edward Hospital/Cancer Center, Naperville
in še 3

Vključevanje udeležencevFaza 3

Starost 18 in več · Moški · Posodobljeno 14. jul. 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Northwestern University, Chicago

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 14. jul. 2026 · NCT05691465

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

Illinois Cancer Specialists, Arlington Heights
Comprehensive Urologic Care, Lake Barrington

Vključevanje udeležencevFaza 1

Starost 18 in več · Moški · Posodobljeno 9. jul. 2026 · NCT05413421

CARE Tool Study Aim 3

Alton Memorial Hospital, Alton

Vključevanje udeležencev

Starost 18 in več · Vsi spoli · Posodobljeno 8. jul. 2026 · NCT07296887

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Northwestern University, Chicago

Vključevanje udeležencevZgodnja faza 1Vabljeni zdravi prostovoljci

Starost 18 in več · Moški · Posodobljeno 2. jul. 2026 · NCT05852041

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci

Starost 19–110 · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT02012699

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Northwestern Medicine Chicago Proton Center, Warrenville

Vključevanje udeležencev

Starost 18 in več · Moški · Posodobljeno 17. jun. 2026 · NCT00969111

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

UChicago Medicine Comprehensive Cancer Center, Chicago

Vključevanje udeležencevFaza 2

Starost 18 in več · Moški · Posodobljeno 16. jun. 2026 · NCT05790213

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

University of Illinois at Chicago, Chicago
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
University of Chicago, Chicago
in še 3

Vključevanje udeležencevOpazovalna študija

Starost 21 in več · Moški · Posodobljeno 22. maj 2026 · NCT03151629

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.